88 related articles for article (PubMed ID: 23566285)
1. Role of NF-κβ and oxidative pathways in atherosclerosis: cross-talk between dyslipidemia and candesartan.
Hadi NR; Yousif NG; Abdulzahra MS; Mohammad BI; Al-Amran FG; Majeed ML; Yousif MG
Cardiovasc Ther; 2013 Dec; 31(6):381-7. PubMed ID: 23566285
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan.
Chen J; Li D; Schaefer R; Mehta JL
Atherosclerosis; 2006 Feb; 184(2):295-301. PubMed ID: 16005008
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin receptor blockade with candesartan attenuates atherosclerosis, plaque disruption, and macrophage accumulation within the plaque in a rabbit model.
Johnstone MT; Perez AS; Nasser I; Stewart R; Vaidya A; Al Ammary F; Schmidt B; Horowitz G; Dolgoff J; Hamilton J; Quist WC
Circulation; 2004 Oct; 110(14):2060-5. PubMed ID: 15451796
[TBL] [Abstract][Full Text] [Related]
4. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS
Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
[TBL] [Abstract][Full Text] [Related]
5. Regression of hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed.
Prasad K
Atherosclerosis; 2008 Mar; 197(1):34-42. PubMed ID: 17904562
[TBL] [Abstract][Full Text] [Related]
6. Effect of candesartan monotherapy on lipid metabolism in patients with hypertension: a retrospective longitudinal survey using data from electronic medical records.
Nishida Y; Takahashi Y; Nakayama T; Soma M; Kitamura N; Asai S
Cardiovasc Diabetol; 2010 Aug; 9():38. PubMed ID: 20712859
[TBL] [Abstract][Full Text] [Related]
7. The anti-atherosclerotic effect of olive leaf extract is related to suppressed inflammatory response in rabbits with experimental atherosclerosis.
Wang L; Geng C; Jiang L; Gong D; Liu D; Yoshimura H; Zhong L
Eur J Nutr; 2008 Aug; 47(5):235-43. PubMed ID: 18654736
[TBL] [Abstract][Full Text] [Related]
8. Regression of atherosclerosis in apolipoprotein E-deficient mice is feasible using high-dose angiotensin receptor blocker, candesartan.
Hayashi K; Sasamura H; Azegami T; Itoh H
J Atheroscler Thromb; 2012; 19(8):736-46. PubMed ID: 22576470
[TBL] [Abstract][Full Text] [Related]
9. [Effect of bushen kangshuai tablet on NF-kappaB signal pathway and inflammation factors in rabbits with experimental atherosclerosis].
Zhang JP; Xu YZ; Li M
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Sep; 29(9):816-20. PubMed ID: 19960980
[TBL] [Abstract][Full Text] [Related]
10. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension.
Yu Y; Fukuda N; Yao EH; Matsumoto T; Kobayashi N; Suzuki R; Tahira Y; Ueno T; Matsumoto K
Am J Hypertens; 2008 Jan; 21(1):72-7. PubMed ID: 18091747
[TBL] [Abstract][Full Text] [Related]
11. Magnolol attenuates VCAM-1 expression in vitro in TNF-alpha-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits.
Chen YH; Lin SJ; Chen JW; Ku HH; Chen YL
Br J Pharmacol; 2002 Jan; 135(1):37-47. PubMed ID: 11786478
[TBL] [Abstract][Full Text] [Related]
12. SCM-198 attenuates early atherosclerotic lesions in hypercholesterolemic rabbits via modulation of the inflammatory and oxidative stress pathways.
Zhang Y; Guo W; Wen Y; Xiong Q; Liu H; Wu J; Zou Y; Zhu Y
Atherosclerosis; 2012 Sep; 224(1):43-50. PubMed ID: 22840690
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of candesartan and rosuvastatin on CD40 and MMPs expression in apo-E knockout mice: novel insights into the role of RAS and dyslipidemia in atherogenesis.
Chen J; Li D; Schaefer RF; Mehta JL
J Cardiovasc Pharmacol; 2004 Oct; 44(4):446-52. PubMed ID: 15454852
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of rupture of atherosclerotic plaque by Candesartan in rabbit model].
Zhou XF; Yin HC; Zhu WL; Shen L; Yu T; Li SA; Meng ZM; Wu AS; Qian HD
Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):106-11. PubMed ID: 20388376
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study of anti-atherosclerosis potency by lycium seed oil and its possible mechanism].
Jiang YD; Cao J; Dong QZ; Wang SR
Zhong Yao Cai; 2007 Jun; 30(6):672-7. PubMed ID: 17918438
[TBL] [Abstract][Full Text] [Related]
16. Sulforaphane attenuates the development of atherosclerosis and improves endothelial dysfunction in hypercholesterolemic rabbits.
Shehatou GS; Suddek GM
Exp Biol Med (Maywood); 2016 Feb; 241(4):426-36. PubMed ID: 26490346
[TBL] [Abstract][Full Text] [Related]
17. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
[TBL] [Abstract][Full Text] [Related]
18. [Aortic expression of monocyte chemotactic protein-1 (MCP-1) gene in rabbits with experimental atherosclerosis].
Sekalska B
Ann Acad Med Stetin; 2003; 49():79-90. PubMed ID: 15552841
[TBL] [Abstract][Full Text] [Related]
19. Candesartan improves memory decline in mice: involvement of AT1 receptors in memory deficit induced by intracerebral streptozotocin.
Tota S; Kamat PK; Awasthi H; Singh N; Raghubir R; Nath C; Hanif K
Behav Brain Res; 2009 May; 199(2):235-40. PubMed ID: 19103228
[TBL] [Abstract][Full Text] [Related]
20. Effects of telmisartan, a unique angiotensin receptor blocker with selective peroxisome proliferator-activated receptor-gamma-modulating activity, on nitric oxide bioavailability and atherosclerotic change.
Ikejima H; Imanishi T; Tsujioka H; Kuroi A; Kobayashi K; Shiomi M; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
J Hypertens; 2008 May; 26(5):964-72. PubMed ID: 18398339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
